These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36111557)

  • 1. Seroconversion rate and socio-economic and ethnic risk factors for SARS-CoV-2 infection in children in a population-based cohort, Germany, June 2020 to February 2021.
    Brinkmann F; Diebner HH; Matenar C; Schlegtendal A; Eitner L; Timmesfeld N; Maier C; Lücke T
    Euro Surveill; 2022 Sep; 27(37):. PubMed ID: 36111557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada.
    Zinszer K; Charland K; Pierce L; Saucier A; McKinnon B; Hamelin MÈ; Cheriet I; Da Torre MB; Carbonneau J; Nguyen CT; De Serres G; Papenburg J; Boivin G; Quach C
    Int J Infect Dis; 2023 Jun; 131():119-126. PubMed ID: 36963656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
    Leidi A; Koegler F; Dumont R; Dubos R; Zaballa ME; Piumatti G; Coen M; Berner A; Darbellay Farhoumand P; Vetter P; Vuilleumier N; Kaiser L; Courvoisier D; Azman AS; Guessous I; Stringhini S;
    Clin Infect Dis; 2022 Mar; 74(4):622-629. PubMed ID: 34043763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada.
    Zinszer K; Charland K; Pierce L; Saucier A; Hamelin MÈ; Da Torre MB; Carbonneau J; Nguyen CT; De Serres G; Papenburg J; Boivin G; Quach C
    Influenza Other Respir Viruses; 2023 Aug; 17(8):e13186. PubMed ID: 37638094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021.
    Sorg AL; Bergfeld L; Jank M; Corman V; Semmler I; Goertz A; Beyerlein A; Verjans E; Wagner N; Von Bernuth H; Lander F; Weil K; Hufnagel M; Spiekerkoetter U; Chao CM; Naehrlich L; Muntau AC; Schulze-Sturm U; Hansen G; Wetzke M; Jung AM; Niehues T; Fricke-Otto S; Von Both U; Huebner J; Behrends U; Liese JG; Schwerk C; Drosten C; Von Kries R; Schroten H
    Nat Commun; 2022 Jun; 13(1):3128. PubMed ID: 35668073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Seroconversion in Children and Adults With Mild COVID-19.
    Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV
    JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020.
    Coyer L; Boyd A; Schinkel J; Agyemang C; Galenkamp H; Koopman ADM; Leenstra T; Moll van Charante EP; van den Born BH; Lok A; Verhoeff A; Zwinderman AH; Jurriaans S; van Vught LA; Stronks K; Prins M
    BMJ Open; 2022 Jan; 12(1):e052752. PubMed ID: 34992110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta and Omicron: protective measures and SARS-CoV-2 infections in day care centres in Germany in the 4th and 5th wave of the pandemic 2021/2022.
    Neuberger F; Grgic M; Buchholz U; Maly-Motta HL; Fackler S; Lehfeld AS; Haas W; Kalicki B; Kuger S
    BMC Public Health; 2022 Nov; 22(1):2106. PubMed ID: 36397006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-prevalence and risk factors for Severe Acute Respiratory Syndrome Coronavirus 2 infection in women and children in a rural district of Bangladesh: A cohort study.
    Khanam R; Islam S; Rahman S; Ahmed S; Islam A; Hasan T; Hasan E; Chowdhury NH; Roy AD; Jaben IA; Nehal AA; Yoshida S; Manu AA; Raqib R; McCollum ED; Shahidullah M; Jehan F; Sazawal S; Bahl R; Baqui AH
    J Glob Health; 2022 Jul; 12():05030. PubMed ID: 35866222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland.
    Ulyte A; Haile SR; Blankenberger J; Radtke T; Puhan MA; Kriemler S
    Swiss Med Wkly; 2022 Jun; 152():w30193. PubMed ID: 35752960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
    Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial, ethnic and socioeconomic disparities in SARS-CoV-2 infection amongst children.
    Mannheim J; Konda S; Logan LK
    Paediatr Perinat Epidemiol; 2022 May; 36(3):337-346. PubMed ID: 35076946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.
    Riccò M
    Acta Biomed; 2022 Jul; 93(3):e2022233. PubMed ID: 35775779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico.
    Fernández-Rojas MA; Luna-Ruiz Esparza MA; Campos-Romero A; Calva-Espinosa DY; Moreno-Camacho JL; Mendlovic F; Plett-Torres T; Alcántar-Fernández J
    Sci Rep; 2022 Mar; 12(1):5241. PubMed ID: 35347208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students.
    Lee CC; Segaloff HE; Cole D; Rosenblum HG; Morgan CN; Somers T; Desamu-Thorpe R; Foster MA; Currie D; Ruff J; Payne D; Whyte TJ; Abedi GR; Bigouette JP; Kahrs J; Langolf K; Remington P; Sterkel A; Kelly P; Westergaard RP; Bateman AC; Hsu CH; Tate JE; Kirking HL
    BMC Infect Dis; 2022 Mar; 22(1):314. PubMed ID: 35361140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
    PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
    Leone V; Meisinger C; Temizel S; Kling E; Gerstlauer M; Frühwald MC; Burkhardt K
    PLoS One; 2022; 17(8):e0272874. PubMed ID: 35951611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.